Our data highlight a reciprocal correlation between the expression of MYB and MAFB in MLL-rearranged AML, thus prompting further studies on MAFB as useful molecular predictor toward MYB pharmacological depletion or inhibition. This evidence concerns the gene MAFB and acute myeloid leukemia.